Shen et al. demonstrated that in hepatocellular carcinoma (HCC), promoter hypermethylation and DNA copy deletion of OGDHL were associated with reduced OGDHL expression, and silencing of OGDHL can further lead to the occurrence and development of HCC by regulating the glutamine metabolism pathway.10 Here, OGDHL is linked to hepatocellular carcinoma.